Marsh & McLennan Companies, Inc. (NYSE:MMC) remains a highly attractive prospect for investors as demonstrated by increased stock acquisitions by numerous wealth and asset management firms including Robeco Institutional Asset Management B.V., Sabal Trust CO and ORG Wealth Partners LLC. The company is strengthening its competitive position by acquiring healthcare analytics business, Validate Health, and insurance broker McGriff Insurance Services. The move to acquire Validate Health demonstrates MMC's strategy to expand its healthcare reach and analytics capabilities. The purchase of Arthur Hall and SECOR Asset Management by MMC bolstered the firm's depth in the industry further. Despite experiencing a modest dip in trading, robust Q1-2025 results, a strong fourth quarter and full-year report in 2024 and continued earnings growth ensures analysts remain bullish on MMC's potential. However, some caution has been expressed regarding the firm's growth speed.
Marsh Mclennan Companies MMC News Analytics from Mon, 30 Sep 2024 07:00:00 GMT to Sat, 28 Jun 2025 12:58:49 GMT -
Rating 8
- Innovation 5
- Information 9
- Rumor -2
